News. 14/06/99

Investeringssällskapet completes the bid of BPA

Press Release

Investeringssällskapet 1999 AB’s (“Investeringssällskapet”) offer to the holders of shares and warrants issued by BPA AB (publ) (“BPA”) has been accepted to the extent that Investeringssällskapet has become the owner of shares and warrants corresponding to 98 per cent of the capital and 98 per cent of the voting rights, after exercise of all warrants. Investeringssällskapet has decided to complete the offer to the holders of shares and warrants in BPA.

In order to offer holders of shares and warrants issued by BPA who have not yet accepted the offer, to participate in the offer, Investeringssällskapet has decided to extend the acceptance period until June 29, 1999.

Settlement for shares and warrants from the original and extended acceptance period will begin on or about June 22, 1999 and July 8, 1999, respectively. Investeringssällskapet will initiate compulsory acquisition as soon as possible. The intention is to delist the shares and warrants issued by BPA at the Stockholm Stock Exchange as of July 5, 1999.

Investeringssällskapet 1999 AB The Board of Directors

For additional information, please contact:

Mikael Ahlström, Investeringssällskapet, Tel: +46 8 506 143 00
Per Blixt, Investor relations, PBA, Tel: +46 8 799 85 16, +46 70 549 28 08

More news.

09/04/24

Polarn O. Pyret appoints Sara Sjöberg as new CEO

Procuritas Capital Investors VI (”Procuritas”), the Swedish private equity firm dedicated to growing Nordic mid-market enterprises, is delighted to announce the appointment of Sara Sjöberg as the forthcoming Chief Executive Officer for its portfolio company, Polarn O. Pyret, the iconic Swedish childrenswear brand. Sara Sjöberg steps into this role with a wealth of experience from...

08/04/24

Humana to acquire Team Olivia’s Norwegian operation

Team Olivia, a leading care service provider in the Nordics has entered into an agreement to sell its Norwegian operations, Team Olivia Norge AS, to Human Care Holding AS (“Humana”). The Transaction is subject to approval by the Norwegian competition authority and is expected to be completed during the second quarter of 2024. Team Olivia,...

28/02/24

Procuritas partners up with Precision BioLogic

Procuritas Capital Investors VII (Procuritas) acquires Precision BioLogic (PBI) and subsidiary (Affinity Biologicals), fast-growing niche leaders in hemostasis diagnostics and research. PBI has in recent years launched a number of successful diagnostics products and is active in a growing market, supported by long-term trends such as ageing population, emerging new therapies, and increased access to...